◆ 会议时间：2020年11月10日至15日 虚拟会议
◆ 会议地点：美国 国家海港/National Harbor
◆ 下届会议：2021年第36届癌症免疫治疗学会年会(SITC2021)
◆ 会议简介：
2020年第35届癌症免疫治疗学会(SITC)年会-虚拟会议将于2020年11月10日至15日举行。SITC年会是世界上最大的专注于癌症免疫治疗的国际盛会，每年的会议和会前教育计划都会吸引超过3500名来自学术界、监管部门和政府机构的国际行业领袖与代表。SITC为与会者提供了一个多学科的教育和互动平台，共同推动科学进步，发现突破性的进展，力求改善所有癌症患者的预后（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。
癌症免疫治疗学会(SITC)成立于1984年，是世界领先的专业致力于通过推进癌症免疫治疗科学与应用来改善癌症患者预后的非营利组织，SITC为来自世界各地的科学家、学者、研究人员、临床医生、政府代表和行业领导者提供服务。目前，SITC拥有超过1700名成员，代表17种医疗专业，从事至少十几种癌症的研究和治疗。SITC的愿景是通过促进科学交流与合作教育计划，旨在让癌症患者被“治愈”在某一天能够成为现实。
35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020)
The Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) will be reimagined as a fully VIRTUAL experience this year to ensure the health and safety of program attendees and their patients, and in celebration of the society’s 35th anniversary, all SITC members are invited to register for FREE!
|
The SITC Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.
Keynote Speakers Announced
Elizabeth M. Jaffee, MD - Sydney Kimmel Cancer Center, Johns Hopkins University
Keynote Address: Turning Immunologically Quiescent Tumors into Immune Responsive Cancers
Helen E. Heslop, MD - Baylor College of Medicine
35th Anniversary Keynote Address: T cell Therapy of Cancer
Important Abstract Dates
| Date |
Details |
April 1, 2020 |
Regular abstracts, Young Investigator Award abstracts, late-breaking abstracts and Immunotherapy Resistance and Failure Pre-Conference Program presentation application submission site opens |
Aug. 25, 2020 |
Regular abstracts, Young Investigator Award abstracts, late-breaking abstracts and Immunotherapy Resistance and Failure Pre-Conference Program presentation application site closes at 5 p.m. PDT |
Sept. 3, 2020 |
Late-breaking abstract application notifications sent |
Sept. 8, 2020 |
Late-breaking abstract submission site opens |
| Sept. 22, 2020 |
Late-breaking abstract submission site closes at 5 p.m. PDT |
Sept. 25, 2020 |
Regular abstract and Young Investigator Award abstract notifications sent |
Sept. 30, 2020
|
Regular abstract presentation acceptance confirmations
Deadline for regular abstract withdrawals and changes
|
Oct. 12, 2020 |
Late-breaking abstract notifications sent |
Oct. 14, 2020 |
Regular abstract title and author information released
|
Oct. 15, 2020 |
Late-breaking abstract confirmation due
Deadline for late-breaking abstract withdrawals and changes
|
Nov. 2, 2020 |
Late-breaking abstract title and author information released |
Nov. 9, 2020 |
Embargo lifted and full regular and late-breaking abstracts made public at 8 a.m. EST
Regular and Young Investigator Award abstract preprint version of supplement published in the Journal for ImmunoTherapy of Cancer (JITC) |
Nov. 10–15, 2020 |
35th Anniversary Annual Meeting & Pre-Conference Programs |
Dec. 9, 2020 |
Late-breaking abstract supplement published in JITC |
Reasons to Submit an Abstract to SITC 2020
- Free submission for members and nonmembers (view important submission dates)
- Young Investigator Awards are offered in conjunction with regular abstract submission
- All accepted abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal
- Multiple oral presentation opportunities available
- The opportunity to present and discuss your research with luminaries in the immunotherapy field
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
